Immuron continued quarterly sales growth Sales Highlights (unaudited): Global • Q1 sales AUD$2.2 million up 9% on prior comparative period (pcp) • Q1 sales up 5% on prior quarter Australia • Q1 sales AUD$1.8 million up 14% on prior comparative period (pcp) • Q1 sales up 12% on prior quarter...
Immuron FY27 Sales Update
Filed with ASX ·
6ix is reading this filing.
In the deck
Story so far
Earlier from Immuron
- Annual Report for Fiscal Year Ending June 30, 2026 (Form 20-F)
- Immuron to launch PROIBS® in the United States
- PROIBS US Distribution Agreement
- Immuron Reports FY26 Preliminary Results
- FY26 Results Presentation
Follow Immuron into a list and get an email when it puts out news.
Follow Immuron